At a glance
ClinicalIndex Comparison RecordN/ACompleted· 27 enrolled
Drug / intervention
Essential Amino Acid (EAA) Supplement +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS
In Brief
A clinical study evaluating Essential Amino Acid (EAA) Supplement and Placebo for Polycystic Ovarian Syndrome and 2 related conditions. Completed, enrolled 27 participants across 1 site.
Detailed Summary
The Investigators will measure hepatic glucose and fat metabolism in obese girls with Polycystic Ovarian Syndrome (PCOS) and hepatic steatosis (HS) after taking 4 weeks of an essential amino acid (EAA) supplement or placebo and test whether the EAA supplement can improve hepatic glucose metabolism in these girls.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovarian Syndrome, Obesity, Hepatic Steatosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
First PostedOct 2018
Primary CompletionJan 2022
TodayJul 2026
First PostedOct 24, 2018
Enrollment StartOct 8, 2018
Primary CompletionJan 14, 2022
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 7.7 years ago
Interventions
Essential Amino Acid (EAA) Supplementdietary
Powder supplement
Placeboother
Powder that will be similar to the essential amino acid supplement